Augmentation of coronary flow reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker

被引：0
|
作者：
Kawata, T
Toyoda, T
Hasegawa, R
Teramoto, K
Sekine, T
Maekawa, S
Lee, K
Uchida, D
Himi, T
Kuwabara, Y
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Kimitsu Chuo Hosp, Kisarazu, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [41] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [42] THE ANTIPROTEINURIC EFFECT OF COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER THERAPY IN PRIMARY GLOMERULONEPHRITIS
    Kaptanogullari, Ozlem Harmankaya
    Ozbahar, Yalcin
    Cecen, Ismail
    Kaptanogullari, Hakan
    NEPHROLOGY, 2005, 10 : A168 - A168
  • [43] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [44] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria
    Chu, Chi D.
    Powe, Neil R.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Crews, Deidra C.
    Saran, Rajiv
    Bragg-Gresham, Jennifer
    Morgenstern, Hal
    Pavkov, Meda E.
    Saydah, Sharon H.
    Tuot, Delphine S.
    HYPERTENSION, 2021, 77 (01) : 94 - 102
  • [45] Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?
    Berns, Jeffrey S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 192 - 196
  • [46] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    G Bönner
    G L Bakris
    D Sica
    M A Weber
    W B White
    A Perez
    C Cao
    A Handley
    S Kupfer
    Journal of Human Hypertension, 2013, 27 : 479 - 486
  • [47] Can an Angiotensin Receptor Blocker Be Used in a Patient in Whom Angioedema Developed With an Angiotensin-Converting Enzyme Inhibitor?
    Cohen, Debbie L.
    Townsend, Raymond R.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (12): : 949 - 950
  • [48] Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
    Rossato, Marco
    Di Vincenzo, Angelo
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [49] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [50] Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure
    Brackbill, Marcia L.
    Bashaw-Keaton, Rebecca
    Sytsma, Christine S.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : 568 - 570
12345